BHCM
CVS icon

Brevan Howard Capital Management’s CVS Health CVS Stock Holding History

Brevan Howard Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.35M Sell
51,694
-23,493
-31% -$2.1M 0.04% 312
2026
Q1 		$5.4M Buy
75,187
+61,929
+467% +$4.77M 0.05% 213
2025
Q4 		$1.05M Buy
13,258
+7,610
+135% +$600K 0.01% 739
2025
Q3 		$426K Sell
5,648
-77,916
-93% -$5.34M ﹤0.01% 1375
2025
Q2 		$5.76M Buy
83,564
+72,182
+634% +$4.73M 0.03% 324
2025
Q1 		$771K Sell
11,382
-13,879
-55% -$831K 0.01% 588
2024
Q4 		$1.13M Buy
+25,261
New +$1.42M 0.01% 400
2024
Q2 		– Sell
-23,654
Closed -$1.89M – 1118
2024
Q1 		$1.89M Sell
23,654
-150
-0.6% -$11.5K 0.02% 159
2023
Q4 		$1.88M Buy
23,804
+20,408
+601% +$1.45M 0.02% 130
2023
Q3 		$237K Buy
+3,396
New +$241K ﹤0.01% 290

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Brevan Howard Capital Management's CVS Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its CVS Health (CVS) stake by 31% in Q2 2026, selling an estimated $2.1M and leaving 51,694 shares worth $5.35M. The position accounts for 0.04% of the portfolio, ranked #312.

Brevan Howard Capital Management first reported a position in CVS in Q3 2023 and has held it in 10 quarters since. The position peaked at $5.76M in Q2 2025. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Brevan Howard Capital Management held 51,694 shares of CVS Health worth $5.35M as of Q2 2026.
  • Brevan Howard Capital Management sold 23,493 CVS Health shares in Q2 2026, an estimated $2.1M.
  • CVS Health made up 0.04% of Brevan Howard Capital Management's portfolio in Q2 2026, its #312 holding.
  • Brevan Howard Capital Management first reported a position in CVS Health in Q3 2023 and has held it in 10 quarters since.
  • Brevan Howard Capital Management's CVS Health position peaked at $5.76M in Q2 2025.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.